The antipsychotic drug chlorpromazine inhibits HERG potassium channels

British Journal of Pharmacology

Volumn 139, Issue 3, 2003, Pages 567-574

  Thomas, Dierk ^a   Wu, Kezhong ^a   Kathöfer, Sven ^a   Katus, Hugo A ^a   Schoels, Wolfgang ^a   Kiehn, Johann ^a   Karle, Christoph A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Antipsychotic drug; Arrhythmia; Chlorpromazine; Ion channels; Long QT syndrome; Xenopus oocytes

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG INHIBITION; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; LONG QT SYNDROME; MICROELECTRODE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TORSADE DES POINTES; VOLTAGE CLAMP; XENOPUS;

EID: 0038678580     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705283     Document Type: Article

References (31)

1. DORSON, P.G. & CRISMON, M.L. (1988). Chlorpromazine accumulation and sudden death in a patient with renal insufficiency. Drug Intell. Clin. Pharm., 22, 776 - 778.
2. DROLET, B., VINCENT, F., RAIL, J., CHAHINE, M., DESCHENES, D., NADEAU, S., KHALIFA, M., HAMELIN, B.A. & TURGEON, J. (1999). Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. J. Pharmacol. Exp. Ther., 288, 1261 - 1268.
3. + channels. Circ. Res., 82, 386 - 395.
4. FICKER, E., THOMAS, D., VISWANATHAN, P.C., DENNIS, A.T., PRIORI, S.G., NAPOLITANO, C., MEMMI, M., WIBLE, B.A., KAUFMAN, E.S., IYENGAR, S., SCHWARTZ, P.J., RUDY, Y. & BROWN, A.M. (2000). Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am. J. Physiol., 279, H1748 - H1756.
5. GLASSMANN, A.H. & BIGGER JR, J.T. (2001). Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am. J. Psychiatry., 158, 1774 - 1782.
6. HADDAD, P.M. & ANDERSON, I.M. (2002). Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs, 62, 1649 - 1671.
7. HOEHNS, J.D., STANFORD, R.H., GERAETS, D.R., SKELLY, K.S., LEE, H.C. & GAUL, B.L. (2001). Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias. Pharmacotherapy, 21, 871 - 883.
8. + channel HERG. Mol. Pharmacol., 59, 122 - 126.
9. KARLE, C.A., KREYE, V.A.W., THOMAS, D., ROCKL, K., KATHOFER, S., ZHANG, W. & KIEHN, J. (2001). Antiarrhythmic drug carvedilol inhibits HERG potassium channels. Cardiovasc. Res., 49, 361 - 370.
10. KIEHN, J., LACERDA, A.E., WIBLE, B.A. & BROWN, A.M. (1996). Molecular physiology and pharmacology of HERG. Circulation, 94, 2572 - 2579.
11. KIEHN, J., THOMAS, D., KARLE, C.A., SCHOLS, W. & KUBLER, W. (1999). Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 212 - 219.
12. LACERDA, A.E., KRAMER, J., SHEN, K.Z., THOMAS, D. & BROWN, A.M. (2001). Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs. Eur. Heart J., 3 (Suppl. K), K23 - K30.
13. 2+ channels in rat pheochromocytoma cells. Biochem. Pharmacol., 58, 1017 - 1024.
14. MITCHESON, J.S., CHEN, J. & SANGUINETTI, M.C. (2000). Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J. Gen. Physiol., 115, 229 - 240.
15. NACCARELLI, G.V., WOLBRETTE, D.L., PATEL, H.M. & LUCK, J.C. (2000). Amiodarone: clinical trials. Curr. Opin. Cardiol., 15, 64 - 72.
16. NAPOLITANO, C., PRIORI, S. & SCHWARTZ, P. (1994). Torsade de pointes: mechanism and management. Drugs, 47, 51 - 65.
17. QUAMME, G.A. (1997). Chlorpromazine activates chloride currents in Xenopus oocytes. Biochim. Biophys. Acta, 1324, 18 - 26.
18. REILLY, J.G., AYIS, S.A., FERRIER, I.N., JONES, S.J. & THOMAS, S.H.L. (2000). QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet, 355, 1048 - 1052.
19. kr potassium channel. Cell, 81, 299 - 307.
20. SMITH, P.L., BAUKROWITZ, T. & YELLEN, G. (1996). The inward rectification mechanism of the HERG cardiac potassium channel. Nature, 379, 833 - 836.
21. SUESSBRICH, H., SCHONHERR, R., HEINEMANN, S.H., ATTALI, B., LANG, F. & BUSCH, A.E. (1997). The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br. J. Pharmacol., 120, 968 - 974.
22. SUESSBRICH, H., WALDEGGER, S., LANG, F. & BUSCH, A.E. (1996). Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett., 385, 77 - 80.
23. TESCHEMACHER, A.G., SEWARD, E.P., HANCOX, J.C. & WITCHEL, H.J. (1999). Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br. J. Pharmacol., 128, 479 - 485.
24. THOMAS, D., GUT, B., WENDT-NORDAHL, G. & KIEHN, J. (2002). The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J. Pharmacol. Exp. Ther., 300, 543 - 548.
25. THOMAS, D., WENDT-NORDAHL, G., ROCKL, K., FICKER, E., BROWN, A.M. & KIEHN, J. (2001). High-affinity blockade of HERG human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. J. Pharmacol. Exp. Ther., 297, 753 - 761.
26. THOMAS, D., ZHANG, W., KARLE, C.A., KATHOFER, S., SCHOLS, W., KUBLER, W. & KIEHN, J. (1999). Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J. Biol. Chem., 274, 27457 - 27462.
27. TIE, H., WALKER, B.D., VALENZUELA, S.M., BREIT, S.N. & CAMPBELL, T.J. (2000). The heart of psychotropic drug therapy. Lancet, 355, 1825.
28. TOKUNAGA, H., KUDO, K., IMAMURA, T., JITSUFUCHI, N., OHTSUKA, Y. & IKEDA, N. (1997). Plasma concentrations of antipsychotic drugs in psychiatric inpatients. Nippon Hoigaku Zasshi, 51, 417 - 422.
29. VISKIN, S. (1999). Long QT syndromes and torsade de pointes. Lancet, 354, 1625 - 1633.
30. WARMKE, J.W. & GANETZKY, B. (1994). A family of potassium channel genes related to eag in Drosophila and mammals. Proc. Natl. Acad. Sci. U.S.A., 91, 3438 - 3442.
31. ZITRON, E., KARLE, C.A., WENDT-NORDAHL, G., KATHOFER, S., ZHANG, W., THOMAS, D., WERETKA, S. & KIEHN, J. (2002). Bertosamil blocks HERG potassium channels in their open and inactivated states. Br. J. Pharmacol., 137, 221 - 228.